CMTM2 and hepatocellular carcinoma: Guo et al.46 have identified that CMTM2 is downregulated in HCC tissues via immunohistochemistry; according to their study, the CMTM2 expression detected by immunohistochemistry may correlate with the tumor grade and prognosis of patients with HCC.